NCT00004441View on ClinicalTrials.gov

Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 1997

Study Completion Date

September 30, 2001

Conditions
Cystic Fibrosis
Interventions
DRUG

tauroursodeoxycholic acid

DRUG

ursodiol

Trial Locations (3)

20122

University of Milan, Milan

80218

Children's Hospital of Denver, Denver

45229-3039

Children's Hospital Medical Center - Cincinnati, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00004441 - Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis | Biotech Hunter | Biotech Hunter